期刊
CANCER LETTERS
卷 447, 期 -, 页码 41-47出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2019.01.015
关键词
Gut microbiome; Cancer; Immunity; Cancer immunotherapy
类别
资金
- Young Scientists Fund of the National Natural Science Foundation of China [81202095]
- Natural Science Foundation of Hubei Province [2016CFB136, 2016CFB550]
Microbiome is becoming crucial in that the balance between human health and disease can be mediated by the gut microbiome. The gut microbiome can modulate the host immune system both locally and systemically. Cancer immunotherapy has emerged as a promising way in the treatment of patients with cancer. Accumulating evidence supports that microbiome affects the therapeutic efficacy of cancer immunotherapy, particularly immune checkpoint inhibitors. Here, we discuss the mutual relationship among gut microbiome, cancer, immunity, and cancer immunotherapy, with a focus on immunotherapy. Also, we briefly introduce the relevant challenges that affect the therapeutic efficacy and present the possible solutions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据